Omega Historical Financial Ratios

OMGA Stock  USD 0.80  0.06  6.98%   
Omega Therapeutics is promptly reporting on over 94 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 902 will help investors to properly organize and evaluate Omega Therapeutics financial condition quickly.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For information on how to trade Omega Stock refer to our How to Trade Omega Stock guide.

About Omega Financial Ratios Analysis

Omega TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Omega Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Omega financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Omega Therapeutics history.

Omega Therapeutics Financial Ratios Chart

At present, Omega Therapeutics' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 2.94, whereas Book Value Per Share is forecasted to decline to 0.86.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Omega Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Omega Therapeutics sales, a figure that is much harder to manipulate than other Omega Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.
Most ratios from Omega Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Omega Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For information on how to trade Omega Stock refer to our How to Trade Omega Stock guide.At present, Omega Therapeutics' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 2.94, whereas Book Value Per Share is forecasted to decline to 0.86.
 2022 2023 2024 (projected)
Graham Number10.336.65.69
Receivables Turnover1.150.440.5

Omega Therapeutics fundamentals Correlations

-0.810.91-0.480.970.930.93-0.811.00.930.93-1.00.9-1.0-0.81.0-0.41-0.851.0-0.77-0.850.880.00.95-0.83-0.85
-0.81-0.730.83-0.85-0.96-0.721.0-0.81-0.96-0.960.81-0.970.810.64-0.810.831.0-0.840.871.0-0.93-0.07-0.921.01.0
0.91-0.73-0.520.790.890.89-0.730.910.890.81-0.910.86-0.93-0.470.92-0.46-0.770.88-0.81-0.770.68-0.270.79-0.75-0.77
-0.480.83-0.52-0.52-0.75-0.570.83-0.48-0.75-0.730.49-0.790.490.27-0.490.980.79-0.520.90.78-0.64-0.02-0.650.80.79
0.97-0.850.79-0.520.910.89-0.850.970.920.96-0.970.9-0.96-0.90.97-0.46-0.880.99-0.75-0.880.960.110.99-0.86-0.88
0.93-0.960.89-0.750.910.87-0.960.931.00.98-0.931.0-0.93-0.670.93-0.72-0.970.94-0.91-0.970.910.00.95-0.96-0.97
0.93-0.720.89-0.570.890.87-0.720.930.870.86-0.930.85-0.94-0.680.93-0.44-0.740.92-0.86-0.740.77-0.010.88-0.72-0.74
-0.811.0-0.730.83-0.85-0.96-0.72-0.81-0.96-0.960.81-0.970.810.64-0.810.831.0-0.840.871.0-0.93-0.07-0.921.01.0
1.0-0.810.91-0.480.970.930.93-0.810.930.93-1.00.91-1.0-0.81.0-0.41-0.851.0-0.77-0.850.880.00.95-0.83-0.85
0.93-0.960.89-0.750.921.00.87-0.960.930.98-0.931.0-0.93-0.670.93-0.72-0.970.94-0.91-0.970.920.010.95-0.96-0.97
0.93-0.960.81-0.730.960.980.86-0.960.930.98-0.930.98-0.92-0.790.93-0.69-0.970.95-0.87-0.970.970.090.99-0.96-0.97
-1.00.81-0.910.49-0.97-0.93-0.930.81-1.0-0.93-0.93-0.911.00.79-1.00.410.85-1.00.780.85-0.880.0-0.950.830.85
0.9-0.970.86-0.790.91.00.85-0.970.911.00.98-0.91-0.91-0.660.91-0.76-0.980.92-0.92-0.980.910.020.95-0.97-0.98
-1.00.81-0.930.49-0.96-0.93-0.940.81-1.0-0.93-0.921.0-0.910.77-1.00.420.85-0.990.790.85-0.870.01-0.940.830.85
-0.80.64-0.470.27-0.9-0.67-0.680.64-0.8-0.67-0.790.79-0.660.77-0.780.210.68-0.830.460.68-0.88-0.36-0.860.650.68
1.0-0.810.92-0.490.970.930.93-0.811.00.930.93-1.00.91-1.0-0.78-0.42-0.851.0-0.78-0.850.88-0.010.94-0.83-0.85
-0.410.83-0.460.98-0.46-0.72-0.440.83-0.41-0.72-0.690.41-0.760.420.21-0.420.79-0.450.830.78-0.61-0.04-0.60.810.79
-0.851.0-0.770.79-0.88-0.97-0.741.0-0.85-0.97-0.970.85-0.980.850.68-0.850.79-0.870.861.0-0.94-0.06-0.931.01.0
1.0-0.840.88-0.520.990.940.92-0.841.00.940.95-1.00.92-0.99-0.831.0-0.45-0.87-0.79-0.870.920.020.97-0.85-0.87
-0.770.87-0.810.9-0.75-0.91-0.860.87-0.77-0.91-0.870.78-0.920.790.46-0.780.830.86-0.790.85-0.750.06-0.830.860.86
-0.851.0-0.770.78-0.88-0.97-0.741.0-0.85-0.97-0.970.85-0.980.850.68-0.850.781.0-0.870.85-0.94-0.06-0.931.01.0
0.88-0.930.68-0.640.960.910.77-0.930.880.920.97-0.880.91-0.87-0.880.88-0.61-0.940.92-0.75-0.940.210.98-0.93-0.94
0.0-0.07-0.27-0.020.110.0-0.01-0.070.00.010.090.00.020.01-0.36-0.01-0.04-0.060.020.06-0.060.210.12-0.06-0.06
0.95-0.920.79-0.650.990.950.88-0.920.950.950.99-0.950.95-0.94-0.860.94-0.6-0.930.97-0.83-0.930.980.12-0.92-0.93
-0.831.0-0.750.8-0.86-0.96-0.721.0-0.83-0.96-0.960.83-0.970.830.65-0.830.811.0-0.850.861.0-0.93-0.06-0.921.0
-0.851.0-0.770.79-0.88-0.97-0.741.0-0.85-0.97-0.970.85-0.980.850.68-0.850.791.0-0.870.861.0-0.94-0.06-0.931.0
Click cells to compare fundamentals

Omega Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Omega Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Therapeutics Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For information on how to trade Omega Stock refer to our How to Trade Omega Stock guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Therapeutics. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.32)
Revenue Per Share
0.114
Quarterly Revenue Growth
1.812
Return On Assets
(0.25)
Return On Equity
(1.29)
The market value of Omega Therapeutics is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Omega Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Therapeutics' market value can be influenced by many factors that don't directly affect Omega Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.